INCY:NASDAQ
Incyte Corp
113,78 $
arrow_upward
+0,93%(+1,04) 1D
7 հոկ, 13:57:07 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
112,82 $
High
115,49 $
Low
112,46 $
Mkt. cap
23,06 մլրդ
Avg. vol.
1,55 մլն
Volume
582,97 հզր
P/E ratio
14,50
52-wk high
132,58 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,74
Shares outstanding
202,70 մլն
No. of employees
3 հզր
Open
112,82 $
High
115,49 $
Low
112,46 $
Mkt. cap
23,06 մլրդ
Avg. vol.
1,55 մլն
Volume
582,97 հզր
P/E ratio
14,50
52-wk high
132,58 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,74
Shares outstanding
202,70 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
AD HOC NEWS
·
18 ժամ առաջ
Stifel raises target for Incyte stock to USD 157
News Corp
·
20 ժամ առաջ
Incyte Corp. stock underperforms Tuesday when compared to competitors
MarketWatch
·
20 ժամ առաջ
Incyte Corp. stock underperforms Tuesday when compared to competitors
AD HOC NEWS
·
1 օր առաջ
Incyte stock gets a USD 157 Stifel price target after pipeline update
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 հզր
Founded2002
HeadquartersՈւիլմինգտոն, Դելավեր, Միացյալ Նահանգներ
Sector-
Websiteincyte.com